Lexaria Bioscience Corp
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
24.8M
on 2026-05-31, from 15.8M on 2024-05-31 10-Q ↗
a raise that quarter, at its price
$5.0M
JonesTrading Institutional Services, agreement of 2024-08-21. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
11.09M
Warrants of every class as tagged in the XBRL facts on 2026-05-31, exercise price $2.09. 10-Q ↗
Cash
2 quarters
$3.6M on 2026-05-31 ÷ $1.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-12-14 | Public offering | 2,661,600 | $1.315 | $3.5M | 424B5 ↗ |
| 2025-09-26 | Public offering | 2,666,667 | $1.50 | $4.0M | 424B5 ↗ |
| 2025-04-24 | Public offering incl. 0.07M pre-funded | 2,000,000 | $1.00 | $2.0M | 424B5 ↗ |
| 2024-10-14 | Public offering | 1,633,987 | $3.06 | $5.0M | 424B5 ↗ |
Also on file: a 1-for-15 reverse split, 2026-07-29 8-K ↗